C07D 491/08
Bridged systems
C07D491/08 (Bridged systems) appears on 590 US grants and 837 published applications in this corpus.
Search patents in C07D- Granted patents
- 590
- Published applications
- 837
- Assignees
- 386
- Inventors
- 3,154
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 4 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 9 |
| 2003 | 7 | 15 |
| 2004 | 7 | 25 |
| 2005 | 7 | 17 |
| 2006 | 19 | 19 |
| 2007 | 11 | 19 |
| 2008 | 10 | 16 |
| 2009 | 17 | 32 |
| 2010 | 16 | 35 |
| 2011 | 18 | 31 |
| 2012 | 19 | 36 |
| 2013 | 37 | 38 |
| 2014 | 37 | 39 |
| 2015 | 32 | 35 |
| 2016 | 27 | 45 |
| 2017 | 37 | 49 |
| 2018 | 38 | 40 |
| 2019 | 31 | 27 |
| 2020 | 20 | 31 |
| 2021 | 28 | 42 |
| 2022 | 21 | 28 |
| 2023 | 19 | 59 |
| 2024 | 26 | 62 |
| 2025 | 27 | 50 |
| 2026 | 20 | 37 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- BRM/BRG1 inhibitors and uses thereof22 Sep 2026US 12,741,966 B2Foghorn Therapeutics Inc.
- Compounds comprising a linker for increasing transcyclooctene stability25 Aug 2026US 12,714,752 B2Tagworks Pharmaceuticals B.V.
- Bicyclic compound and use thereof25 Aug 2026US 12,715,866 B2SK Biopharmaceuticals Co., Ltd.
- Macrocyclic diamine derivatives as ENT inhibitors for the treatment of cancers, and combination thereof with adenosine receptor antagonists25 Aug 2026US 12,715,880 B2iTeos Belgium SA
- Phenyl- and pyridopyrazole derivatives as inhibitors of DDR128 Jul 2026US 12,692,247 B2Redx Pharma PLC
- Compounds for the degradation of mutant braf1 Oct 2026US 2026/0297060 A1C4 Therapeutics, Inc.
- Novel benzimidazolone derivative compound as autotaxin inhibitor10 Sep 2026US 2026/0265265 A1LG Chem.Ltd.
- Epoxy compound and use thereof10 Sep 2026US 2026/0265270 A1Shanghai Huilun Pharmaceutical Co., Ltd.
- Immunoassays for Buprenorphine and Metabolites20 Aug 2026US 2026/0243783 A1
- Methods and systems that normalize images, generate quantitative enhancement maps, and generate synthetically enhanced images13 Aug 2026US 2026/0234138 A1AI Analysis, Inc.
Most cited
By later US patents
- Apoptosis promoters226US 7,390,799 B2Abbott Laboratories · 2008
- Aryl- or heteroaryl-substituted benzene compounds82US 8,410,088 B2Eisai R&D Management Co., Ltd. · 2013
- Supports for oligomer synthesis78US 7,202,264 B2Isis Pharmaceuticals, Inc. · 2007
- Aryl- or heteroaryl-substituted benzene compounds59US 8,765,732 B2Epizyme, Inc. · 2014
- Apoptosis promoters52US 7,973,161 B2Abbott Laboratories · 2011